At IgY Life Sciences, we are determined to revolutionize healthcare through the science of IgY Technology. We are a biotechnology company focused on developing and manufacturing novel, immune-based products. Our mission is to actualize the promise of IgY Technology to enable humans and animals to live healthy lives.

​

The potential for IgY Technology to be the foundation of a new generation of therapeutics is unlimited.

 

​

We are  pioneers in the development and manufacturing of
IgY Antibodies.

Our proprietary MASON Extraction Methodology™ makes it possible to create immune health solutions that address a broad spectrum of human and animal health needs. 

​

Our team is advancing a rich pipeline of human and animal health solutions. We are currently developing solutions for challenges ranging from the Coronavirus to African Swine Fever with the objective to rapidly advance multiple candidates into clinical development. We are also advancing a number of consumer immune  health solutions. 

​

We are dedicated to becoming the global leader in IgY Technology. We welcome the opportunity to build long term relationships with like-minded investors and partners. We are working on a number of products at various stages of development and interested in working with organizations passionate about advancing the vision.

​

​